Motif Bio plc | CIK:0001674657 | 3

  • Filed: 4/10/2018
  • Entity registrant name: Motif Bio plc (CIK: 0001674657)
  • Generator: Merrill
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1674657/000110465918023117/0001104659-18-023117-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1674657/000110465918023117/mtfb-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001674657
  • Open this page in separate window: Click
  • ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory

     

    b.Segment reporting

     

    The chief operating decision-maker is considered to be the Board of Directors of Motif Bio plc. The chief operating decision-maker allocates resources and assesses performance of the business and other activities at the operating segment level. In addition, they review the IFRS consolidated financial statements.

     

    The chief operating decision-maker has determined that Motif has one operating segment to support its strategy for the development and commercialization of pharmaceutical formulations. The Group maintains space and has some activities in the U.K.; however, the finance and most other management functions take place in the U.S.